IL1B and ischemic stroke: Similarly, the IL-1β and IL-18 serums showed a significant increase at 24 h after ischemic stroke (Figure 4C,D for IL-1β, * p < 0.05 vs. Sham group; for IL-18, *** p < 0.001 vs. Sham group).